Peter Eicker

The board convened for a special meeting, during which it moved into executive session to discuss limited personnel matters, including issues such as hiring, promotion, demotion, dismissal, assignment, or resignation. Upon returning to open session, the board ratified the decision reached during the closed executive session regarding these personnel matters.

The key discussion point involved a motion made by the Chair to enter into an Executive Session for the discussion of limited personnel matters, specifically regarding hiring, promotion, dismissal, investigation, or consideration of complaints against public employees, pursuant to NMSA 1978, Section 10-15-1 (H) (2) of the Open Meetings Act. The Board subsequently returned to open session, and with no further business, the meeting was adjourned.

The board meeting, spanning two days, involved several key actions taken during both open and executive sessions. Discussions in executive session included the status of HPWP participants, informal compliance interviews, and matters related to personnel and pending litigation. In open session, the agenda and minutes from previous meetings were approved. Significant actions included closing multiple complaint cases (NMMB-20240214, NMMB-20240215, NMMB-20240335, etc.), offering a stipulated license contingent on HPWP monitoring for case NMMB-20250315, and granting full licenses for case NMMB-20250316. Licensing actions involved accepting a Default Order and revoking the medical license of Ester Han, M.D., and approving a Stipulation and Order for Jennifer McCain, D.O. Updates were also provided on telemedicine rule proposals concerning out-of-state registration, post-graduate training requirements, and licensure fees. The Board approved updated policies for IV use, Artificial Intelligence (AI), Cannabis use by Licensees, and Self-Prescribing. Licensing statistics and financial reports showing revenue exceeding budgeted targets were presented. Finally, the Board approved changes to the Protocol of Pharmacists Prescribing Vaccines.

The meeting involved the approval of the agenda and previous minutes from May 1-2, 2025, and a Special Board Meeting from June 5, 2025. Discussions included the Executive Director's report, leading to an executive session for limited personnel matters. In open session, the Board Chair discussed the Complaint Algorithm, which was subsequently approved. The Medical Director presented policy updates for the IV Policy, AI Policy, Cannabis Use by Licensee Policy, Self-Prescribing Policy, and Ketamine Policy; the approval of these policies was tabled pending review by a newly formed committee. The Finance report addressed an amended FY26 Operating Budget amount. The Committee A reports from the Complaint Committee recommended closing several cases without restriction and tabling one case for further investigation. Licensing requests included review and decision on the Hearing Officer's Report for Aman Patel, MD, which resulted in the revocation of his license. Additionally, the Board granted a Motion for Entry of Default Order Revoking Dr. Gregory Roth's License. The meeting concluded with updates on new hires and upcoming events.

The board meeting, held over two days, covered several key areas. Discussions included reports from the Health Professional Wellness Program (HPWP) regarding participant status and future program reviews, as well as informal compliance interviews. In open session, decisions were made on numerous complaint cases, resulting in closures, the issuance of advisory letters, a Notice of Contemplated Action, and licensure decisions including denials, stipulations, and full unrestricted licenses. Reports from the Interim Executive Director highlighted staff changes, conference attendance, and potential fee increases due to a financial deficit. The Chair reported on various strategic topics such as Telemedicine, Compacts, and Foreign Trained Physicians. The Licensing Manager provided detailed statistics on pending and issued licenses and discussed tracking active New Mexico practitioners. The CFO presented the budget revenue status ending March 31, 2025, and the approval of the FY26 Operating Budget. Old business included the re-election of current officers and the adoption of the Open Meetings Act. New business featured further discussion on the HPWP, data analytics projects to improve decision-making efficiency, and the approval of a six-month inpatient rotation for psychiatric residents. Licensing actions included the acceptance of an Entry of Default Order and the revocation of a license for one physician.